Centessa Pharmaceuticals plc
CNTA · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $1,917 | $766 | $290 | $1,013 |
| - Cash | $383 | $128 | $394 | $595 |
| + Debt | $117 | $85 | $70 | $76 |
| Enterprise Value | $1,651 | $722 | -$34 | $494 |
| Revenue | $0 | $7 | $0 | $0 |
| % Growth | -100% | – | – | – |
| Gross Profit | $0 | $7 | $0 | $0 |
| % Margin | – | 100% | – | – |
| EBITDA | -$222 | -$165 | -$210 | -$139 |
| % Margin | – | -2,413.9% | – | – |
| Net Income | -$236 | -$151 | -$216 | -$382 |
| % Margin | – | -2,204.7% | – | – |
| EPS Diluted | -2.06 | -1.57 | -2.31 | -4.24 |
| % Growth | -31.2% | 32% | 45.5% | – |
| Operating Cash Flow | -$142 | -$160 | -$201 | -$136 |
| Capital Expenditures | -$0 | -$0 | -$1 | -$0 |
| Free Cash Flow | -$142 | -$161 | -$202 | -$136 |